|
⚲
|
| Keyboard |
| 1207 Capital Group LLC
✚
|
|
|---|---|
| CRD # | 162611 |
| SEC # | 801-76747 |
| CIK # | |
| AUM | 162.7 M (2026-03-30) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 312-690-6201 |
| Address | 119 Seward Street Juneau, AK 99801 |
| Source | [IAPD] [Website] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 5 – Fees and Compensation The fees and expenses for each Private Fund are described in detail in the associated Private Offering Memorandum. In general, each Private Fund pays the Manager an advisory fee (also referred to as a “Management Fee”) and an incentive allocation based on fund performance (which, in the case of Cimarron Venture Opportunities, LP, is referred to as “carried interest”). Different investors in the Private Funds may pay different fees. The advisory fee for Cimarron Partners, LP, Cimarron Healthcare Opportunities, LP, and Cimarron Energy Spectrum, LP (also known as the management or administrative fee) is generally 1% per annum. The advisory fee for Cimarron Venture Opportunities, LP is generally 0.75% per annum. Management Fees for Cimarron Partners, LP and Cimarron Energy Spectrum, LP are payable in advance on the first day of each month and are based on the capital account balances of the partners as of the beginning of each such month. Management Fees for Cimarron Venture Opportunities, LP are payable in advance on the first day of each calendar quarter and are based on each partner’s aggregate capital contributions as of the start of such quarter. Management Fees for Cimarron Healthcare Opportunities, LP are payable in arrears on the last day of each month and are based on the capital account balances of the partners as of the end of such month. 1207 Capital Group, LLC Form ADV Part 2A (March 2026) If earned due to performance of Cimarron Partners, Cimarron Healthcare Opportunities, Cimarron Energy Spectrum, and Cimarron Venture Opportunities, performance-based fees in the form of incentive allocations or carried interest are charged to most partners at 10% of net new profits. The incentive allocations for Cimarron Partners, Cimarron Healthcare Opportunities, and Cimarron Energy Spectrum are subject to a customary high-water mark, and are assessed annually and at the time of redemption. The carried interest for Cimarron Venture Opportunities, if earned, is disbursed upon distribution of the partnership’s profits. For purposes of computing the Management Fee, Net Assets will be determined before any accrued but unpaid Incentive Allocation. Incentive allocations are subject to high water mark provisions described in detail in the Private Offering Memorandum for each fund. The incentive allocation for Cimarron Healthcare Opportunities, LP is also subject to a 6% annualized threshold rate of return as described in detail in the Private Offering Memorandum for the fund. The calculations of incentive allocations and carried interest are complex, and Private Fund investors and prospective investors should carefully review the more detailed terms set forth in the Private Funds’ offering and governing documents. In addition to these fees, the partners’ capital accounts are subject to various expenses including but not limited to: audit, legal, administrative accounting, and formation costs. The Manager has made, and may make in the future, exceptions to its general fee schedule in its sole discretion based on various circumstances. All fees are deducted from a partner’s share of the Partnership by the fund administrator. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Cimarron Venture Opportunities LP | [2021-03-30] | 9.2 M | 12.2 M |
| Filed 2026-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Cimarron Energy Spectrum LP | [2015-03-30] | 18.7 M | 6.7 M |
| Filed 2026-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Cimarron Healthcare Opportunities LP | [2013-03-15] | 39.9 M | 112.1 M |
| Filed 2026-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Cimarron Partners LP | [2012-05-25] | 91.2 M | 31.7 M |
| Filed 2026-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $1 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Cimarron Vista LP | 2012-05-25 | 6.5 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 162.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 162.7 |
| By Discretionary | ||
| Discretionary | 4 | 162.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 162.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 162.7 | |
| Total | 4 | 162.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| 1207 Capital Group LLC | Director, Executive Officer | 5 | 2 | |
| Robert Jernigan | Executive Officer | 4 | 2 | |
| R Mark Jernigan | Executive Officer | 4 | 2 |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.1B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 2549007XNIJ3CDC0ET37 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Hudson Executive Capital LP
✚
|
NY | 178.1 M |
|
Oppenheimer Alternative Investment Management LLC
✚
|
NY | 177.8 M |
|
Newport Global Advisors LP
✚
|
TX | 174.8 M |
|
Arrow Capital Management LLC
✚
|
NY | 174.8 M |
|
Unlimited Funds Inc
✚
|
NY | 174.5 M |
|
Nihon Global Growth Partners Management Inc
✚
|
NY | 163.3 M |
|
Merida Capital Holdings LLC
✚
|
NY | 157.3 M |
|
Ivy Evergreen LLC
✚
|
SC | 155.0 M |
|
The Lind Partners LLC
✚
|
NY | 153.1 M |
|
Leo Fund Services LLC
✚
|
NJ | 151.3 M |